Aims We investigated the association between cumulative lifetime and current marijuana use with total abdominal adipose tissue (AT), visceral AT, subcutaneous AT, intermuscular AT, and mean liver attenuation (LA) at mid-life. Findings In 2010-2011, 84% of participants reported a history of marijuana use with 11% reporting use within the past 30 days. Before adjustment, we observed greater cumulative marijuana use was associated with lower total abdominal and subcutaneous AT volume and lower LA and current marijuana use was associated with lower subcutaneous AT. However, after adjustment for age, sex, race, field center, cigarette pack-years and current use, regular alcohol consumption, cumulative drink-years, and physical activity, neither cumulative marijuana use nor current use showed an association with any abdominal adipose depot. Our estimates did not differ by age, sex, or race nor after accounting for cohort attrition. Conclusion Neither cumulative marijuana use nor current marijuana use is associated with total abdominal, visceral, subcutaneous, or intermuscular adipose tissue, or liver attenuation in mid-life.
INTRODUCTION
Marijuana is one of the 3 most used psychoactive substances in the United States (US), with nearly 38 million individuals 12 years of age and older using marijuana during the past year in 2016 [1] . Whether the growing utilization of marijuana for medicinal use has an impact on the prevalence of recreational use and abuse/dependence is unclear [2] [3] [4] . Acute cardiovascular health effects of marijuana use include increased heart rate [5] , trigger for myocardial infarction [6] , and acute respiratory conditions [7, 8] . Data on the chronic health effects associated with long-term marijuana use yield mixed findings [7, 9] . It is unclear whether marijuana use is associated with the incidence of cancer [10] [11] [12] [13] or pulmonary disease and poorer pulmonary function [14] [15] [16] [17] [18] , but data suggest no association of marijuana use with diabetes [19] or mortality [20] . Given the prevalence of marijuana use, mounting medicinal use, potential for respiratory harm, and the limited understanding of population-level health effects, greater attention is warranted to the potential chronic health outcomes associated with this modifiable behavior.
The primary active component in marijuana, delta-9 tetrahydrocannabinol (THC), is shown to activate cannabinoid receptors that are integral to regulating energy metabolism via appetite control, lipid metabolism, and energy expenditure [21] . To date, studies assessing marijuana use and various metabolic parameters yield conflicting results. Greater long-term marijuana use is associated with higher caloric intake [22] and incident prediabetes [19] , but not with incident diabetes [19] . The prevalence of obesity and odds of metabolic syndrome and nonalcoholic fatty liver disease (NAFLD) are lower in cannabis users than in nonusers, though cannabis use is not consistently associated with lower body mass index (BMI), waist circumference (WC), and insulin resistance [22] [23] [24] [25] [26] [27] [28] [29] . Heavy chronic marijuana users are shown to have greater percentage of visceral adiposity compared to matched nonusers, but do not display differences in percentage of total or subcutaneous adiposity [26] . In view of the high prevalence of overweight/obesity in the US and the suggestion for cannabinoids as a possible treatment option [21] , the relationship between long-term marijuana use and abdominal adiposity in a community-based population merits investigation. Furthermore, detailed assessment of health behaviors such as physical activity, alcohol consumption, and tobacco use should be included when evaluating metabolic health effects of marijuana use, to address potential confounding [30, 31] . Our objective was to quantify differences in total abdominal adipose tissue (AT), visceral AT, subcutaneous AT, intermuscular AT, and mean liver attenuation (LA) at midlife according to cumulative use and concurrent use of marijuana.
METHODS
The Coronary Artery Risk Development in Young Adults (CARDIA) study is an ongoing longitudinal observational study of individuals recruited from four US metropolitan communities. In 1985-1986, a total of 5115 black and white adults who were 18-30 years of age and free from cardiovascular disease were enrolled. Participants have been contacted by telephone annually and invited to participate in follow-up examinations 2, 5, 7, 10, 15, 20, 25, and 30 (2015-2016) years after baseline. Participants have provided consent at each examination and Institutional Review at each study site and coordinating center have granted approval for all exams. Details regarding the study design have been published previously [32] .
Standardized protocols, harmonized over time, and structured questionnaires were used at CARDIA clinical examinations to collect information on demographics, blood pressure, anthropometry, chemistries, medical and family history, use of medications, and behavioral health characteristics. Body weight was measured using a calibrated balance beam scale to the nearest 0.2 kg and height was measured to the nearest 0.5 cm using a vertical ruler. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared. Educational level was determined as the educational grade attained for participants at each visit, categorized at maximum attainment (≤ 12 years of education, 13-16 years, or >16 years). At each exam, individuals completed a selfadministered questionnaire covering their history of tobacco use. From this data, we derived cigarette smoking status (never, former, current) and estimated lifetime exposure to cigarettes in terms of cigarette pack-years, with 1 pack of cigarettes equivalent to 20 individual cigarettes and 1 pack-year equivalent to smoking 1 pack of cigarettes per day for 1 year. Participants reported regular consumption of alcohol over the previous week, including beer, wine, and liquor and were categorized according to standard habitual alcohol consumption levels (no regular; moderate consumption: up to 1 drink daily for women, 2 drinks daily for men; or heavy consumption: greater than 1 drink daily for women, 2 drinks daily for men) [33] . From this data we also estimated the cumulative alcohol consumption in drink-years for each individual at each exam, with 1 drink-year defined as consuming 1 drink per day for 1 year, summing across exams. Self-reported sports-related physical activity was assessed as the frequency of participation over the previous 12 months for 8 vigorous-intensity and 5 moderate-intensity activities using a questionnaire with high reliability [34] . CARDIA researchers derived an overall physical activity score, in "exercise units" (EU), with a score of 300 EU corresponding to 30 minutes of moderate physical activity 5 times per week [35] .
Marijuana use
Marijuana use was assessed at each exam using detailed self-administered questionnaires, similar to those used for the National Survey on Drug Use and Health [1] . We used responses from the following survey questions to estimate cumulative and current marijuana use: "Have you ever used marijuana? About how many times in your lifetime have you used marijuana? During the last 30 days, on how many days did you use marijuana?" Current use was an affirmative to using marijuana in the past 30 days. We derived a cumulative marijuana use variable between CARDIA exams, marijuana-years, as the product-term of the number of days of using marijuana in the past 30 days and the duration between midpoints of successive exams. Cumulative lifetime marijuana use was calculated as the sum of cumulative marijuana use between CARDIA exams and the baseline examination direct response to lifetime marijuana use and we used the directly self-reported lifetime estimate whenever the derived cumulative estimate was lower than the directly self-reported lifetime estimate, consistent with other CARDIA analyses [14] . Other drug use was assessed in similar fashion for crack/cocaine, amphetamines, and opiates.
Computed tomography
The computed tomography (CT) protocol has been described previously [36] . Briefly, non-contrast CT with multi-detector General Electric (GE) or Siemens scanners was used to obtain CT images at each field center at examination year 25 Image analysis and quality control were performed at a central reading center (Wake Forest University Health Sciences, Winston-Salem, North Carolina). The CTscanning protocol included scout images of the abdomen, an ECG gated chest series, and a lower abdomen series. Volume of adipose tissue was measured within a 10 millimeter (mm) block of slices centered between the 4th and 5th (L4-L5) lumbar vertebrae. Medical Image Processing, Analysis, and Visualization software (http://mipav.cit.nih.gov/index.php) was used to segment and quantify volume, in milliliters (mL), of visceral, subcutaneous, and intermuscular AT within each compartment. Liver attenuation (LA) was measured in Hounsfield Units (HU) in the right lobe of the liver using 2.5 to 3.0 mm thick images of the chest series images in the upper abdomen. Mean LA was calculated as the average of nine measurements from three slices using 2.6 cm 3 regions of interest (ROI). Readers were trained to place the liver regions of interest avoiding the large vessels and any focal liver lesions [37] . As the amount of liver fat increases, the measured LA decreases [37] . In a subsample of 156 blinded scans, the intra-class correlation for inter-reader comparisons for visceral AT, intermuscular AT of the right psoas muscle, and LA (from 3 ROI) were 0.989, 0.948, and 0.958 to 0.975, respectively. Intra-and inter-reader technical error were low, 2.4% and 6.7% for visceral AT, 8.1% and 7.6% for right psoas intermuscular AT, and 2.7% to 3.2% and 4.1% to 5.3% for LA (from 3 ROI).
Statistical analysis
Of the 3499 participants attending the CARDIA year 25 exam, 318 individuals were excluded from CT due to reasons of current pregnancy, body weight in excess of 450 lbs or were unable to fit within the CT gantry. An additional 24 individuals who had inadequate or missing measurement for total abdominal, visceral, subcutaneous, intermuscular AT, or LA were excluded. Of the remaining 3157 individuals with CT data, we excluded participants with self-reported liver disease (n = 88), risk factors for chronic liver disease: self-reported HIV (n = 24) and previous intravenous drug use (n = 51), and individuals who were missing covariate data (n = 92) for an analytic sample of 2902 for the four adipose tissue depots. For analyses of LA, we further excluded individuals with potential secondary causes of hepatic steatosis including regular alcohol consumption ≥20 g/day for women and ≥30 g/day for men (n = 308) and current hormone therapy (n = 116) resulting in an analytic sample of 2478. [38] Characteristics of those excluded from analysis are presented in Supplementary Table 1 .
We modeled cumulative lifetime marijuana use through exam year 25, as a 5-level categorical variable based on cumulative marijuana-years: none, less than 0.5 marijuana-years, 0.5 to <2 marijuana-years, 2 to <5 marijuana-years, and ≥5 marijuana-years, consistent with previous CARDIA analyses [39, 40] . We generated categorical current marijuana use status at year 25 as times of use in past 30 days (none, 1-9 times, 10-19 times, and ≥20 times). Participant characteristics measured at CARDIA examination year 25 were summarized across category of cumulative use. Our outcomes of interest were total abdominal, visceral, subcutaneous, and intermuscular AT, and mean LA measured at year 25. All volumes were determined to be normally distributed and we used multivariable linear regression to assess the mean difference (and standard deviation, SD) in tissue volumes according to cumulative marijuana use category compared to individuals who reported zero lifetime use. We assessed the association between cumulative and current marijuana use and each outcome with an unadjusted model, two sequentially adjusted models, and a fourth model accounting for cohort attrition. The first adjusted model included age, sex, race, field center, and educational attainment. The second adjusted model included adjustment for the previous characteristics in addition to cigarette pack-years, current cigarette smoking status, regular alcohol consumption, cumulative drink-years, and regular sports-related physical activity. Individuals with high marijuana use and high abdominal adiposity may have a higher risk of being lost to follow-up before year 25 and excluded from CT scan. Therefore, for the fourth model we used inverse probability of attrition weighting (IPAW) to examine the influence of selective attrition on our estimates [41] . The objective of IPAW is to create a pseudo-population representative of the original population, wherein individuals who are followed completely who have characteristics similar to those of individuals who are lost to follow-up provide greater weight to the analysis. These methods are detailed in the supplementary material. We assessed statistical interaction of each association by age, sex, and race. We assessed linear trend in estimates across marijuana use category by assigning the median marijuana-years to each individual in the respective marijuana use category and entering this variable into a separate regression model. We assessed non-linear associations modeling marijuanayears as a 2 nd order quadratic polynomial continuous variable. We also assessed the sensitivity of our estimates to other drug use, including cumulative use of crack/cocaine, amphetamines, and opiates into our final model. All statistical analyses was performed using SAS statistical software version 9.4 (SAS Institute Inc., Cary, NC).
RESULTS
Of the 2902 individuals included in this analysis, 57% were women, 48% were black, and the mean age was 50.6 years (SD = 3.6 years) at the time of CT. The proportion of individuals who reported never using marijuana was 16% (n = 476), with 54% (n = 1578), 16% (n = 463), 6% (n = 183), and 7% (n = 202) reporting less than 0.5 marijuana-years of use, 0.5 to <2 marijuana-years of use, 2 to <5 marijuana-years of use, and ≥5 marijuanayears of use, respectively ( Table 1 ). The mean (± SD) total marijuana-years at CARDIA exam year 25 was 1.2 marijuana-years (± 3.0). The percentage of the sample who reported using marijuana in the past 30 days at exam year 25 was 11% and current use was positively associated with cumulative marijuana-years. Of the total sample, 5%
reported marijuana use of 1-9 times in past 30 days (n = 152), 2% reported marijuana use of 10-19 times in past 30 days (n = 63), and 4% reported marijuana use of 20 or more times in past 30 days (n = 106). At year 25, other characteristics positively associated with greater cumulative marijuana-years included male sex, current cigarette smoking, greater cigarette pack-years, physical activity, and cumulative alcohol drink-years. In contrast, educational attainment and BMI were inversely associated with greater cumulative marijuana-years. Descriptive statistics for total abdominal, visceral, subcutaneous, intermuscular AT, and LA according to participant characteristics can be found in Supplementary Table  2 . The mean (± SD) total abdominal AT, visceral AT, subcutaneous AT, intermuscular AT, and LA was 484.6 mL (± 216.5), 130.5 mL (± 72.9), 335.9 mL (± 169.9), 18.2 mL (± 11.1), and 55.5 HU (± 11.8). On average, women had greater volumes of total abdominal and subcutaneous AT, lower volume of visceral AT, and less liver fat. Intermuscular AT did not differ by sex. Furthermore, compared to whites, blacks had greater mean volumes of total abdominal and subcutaneous AT, lower mean volumes of visceral and intermuscular AT, and less liver fat. At year 25, greater physical activity was inversely associated with each adipose tissue depot and positively associated with mean LA. Current cigarette smoking was associated with lower total abdominal and subcutaneous AT volumes and greater intermuscular AT volume. Greater regular alcohol intake was associated with lower total abdominal and subcutaneous AT. Greater education was associated with lower total abdominal and subcutaneous AT volume. The results from multivariable adjusted linear regression models are presented in Tables 2 and 3 . Before adjustment, greater cumulative marijuana use, according to marijuana-years category, was associated with lower total abdominal and subcutaneous AT volume and lower LA ( Table 2) . We consistently observed individuals with the greatest marijuana-years had significantly (P < 0.05) lower total abdominal and subcutaneous AT volume and lower LA (greater liver fat) compared with the reference category (none) and we observed significant linear trend in the volume estimates across marijuana use category. However, after adjustment for age, sex, race, field center, and education, cumulative marijuana use was not associated with any of the abdominal adipose tissue depots or liver attenuation at CARDIA exam year 25 and remained not associated after further adjustment for lifestyle characteristics. For all marijuana use and adipose depots associations, the greatest attenuation in estimates was observed after adjustment for regular alcohol consumption. We did not find evidence for a linear trend across category of cumulative marijuana-years or when modeling marijuana-years continuously with a quadratic term (P > 0.10, figures in Supplement). Similarly, greater current marijuana use at exam year 25 was not significantly associated with total abdominal AT, visceral AT, intermuscular AT, or LA before or after adjustment (Table 3) . Before adjustment, greater current marijuana use appeared to be associated with lower subcutaneous AT. This association was explained with adjustment for demographics and lifestyle characteristics. When current marijuana use was assessed as yes or no, current use was not associated with any adipose tissue volume or LA. We did not find evidence for an interaction in the association between cumulative marijuana use or current marijuana use and any of the outcomes by age, sex, or race (all p for interaction >0.05). The mean ± SD of the attrition weights was 0.99 ± 0.09 (range: 0.72, 2.05). Employing IPAW in our modeling technique did not alter our primary results (Tables 2 and 3 ) nor did inclusion of cumulative use of crack/cocaine, amphetamines, and opiates to our final model (not shown).
DISCUSSION
The main findings from this analysis were that cumulative lifetime marijuana use from young adulthood through 25 years later was not associated with volume of total abdominal adipose tissue, visceral adipose tissue, subcutaneous adipose tissue, intermuscular adipose tissue, or mean liver attenuation in middle adulthood. Furthermore, we did not observe an association between current use of marijuana and any abdominal adipose tissue depot. We did not observe variation in our results by age, sex, or race. Lastly, we did not find evidence that our results were influenced by cohort attrition.
Epidemiological data on the association between marijuana use and abdominal adipose tissue accumulation are limited. One previous cross-sectional study examined differences in abdominal adipose tissue depots between 30 current heavy cannabis users and 30 matched nonusers (matched by age, sex, ethnicity, and BMI) [26] . While current cannabis users had lower absolute total body fat and subcutaneous fat, they also had greater percentage visceral fat (% of total abdominal fat) compared to nonusers, with no differences between the two groups in percentage of total body or subcutaneous fat or absolute volume of hepatic fat [26] . However, beyond matching criteria, no modeling adjustments were made for important potential confounding factors such as alcohol and tobacco use, which may impact weight and metabolism [30] . This is particularly concerning when concomitant tobacco use exceeded 50% among the cannabis smokers compared to 7% concomitant tobacco use among non-cannabis users in this study [26] . Investigation of marijuana use and proxies of general adiposity and abdominal adiposity, BMI and WC, is limited and conflicting. Data from the Nunavik Inuit Health Study showed a cross-sectional association between current marijuana use and lower percent body fat and BMI [27] . A large cross-sectional study of US residents using inpatient data and patient discharge records observed lower prevalence of NAFLD among current cannabis users compared to non-users [29] . Long-term marijuana use was not assessed for either study. The association between current marijuana use and lower BMI and WC in adults has been observed in some cohorts [23, 25, 28] and not others [28] , and even showed an opposite direction of association in adolescent girls [42] . However, longitudinal investigation of substance use in adolescents found baseline marijuana use was not associated with subsequent BMI [43] . Previous prospective analysis in CARDIA has found greater lifetime marijuana use was not associated with BMI but was associated with lower waist circumference [22] .
The principal active ingredient of cannabis is THC, which acts on cannabinoid receptors 1 (CB 1 ) and 2 (CB 2 ) in the brain and peripheral tissues [21, 44] . Habitual cannabis use is associated with down regulation of CB receptors, reversible with cessation of use [45] . Activation of these receptors and the endocannabinoid system is thought to affect appetite regulation and energy and tissue metabolism [21] . THC may accrue and be stored in adipose tissue and subsequently released from adipocytes during lipolysis [46, 47] . In rat models, administration of THC resulted in a paradoxical phenomenon of decreased food intake and reduced body weight while promoting epididymal adipocyte hypertrophy and greater macrophage infiltration of adipocytes [48] . This suggests specific action of THC in visceral adipocytes. Consistent with this, clinical trials of CB 1 receptor antagonists in obese individuals have shown significant reductions in visceral, subcutaneous, and liver fat when compared with placebo [49] . Together these clinical and animal data suggest the endocannabinoid system has a role in adipocyte tissue accumulation and inflammation. Our findings are germane to the general public and to clinicians, particularly considering the corollaries of increased abdominal adiposity and the general lack of prospective data on marijuana use and health outcomes. Greater visceral adiposity is associated with increased incidence of type 2 diabetes and coronary artery calcium progression, both strong risk factors for major cardiovascular events [50, 51] . Greater cumulative marijuana use was not consistently associated with developing prediabetes and diabetes in CARDIA [19] . Marijuana use is shown to be an acute trigger for myocardial infarction (MI) [6] .
However, for individuals presenting with acute myocardial infarction (MI), marijuana use in the preceding year was not significantly associated with greater mortality in the years following MI [52] . In CARDIA, marijuana use during young adulthood was not associated with incident cardiovascular disease over 26 years of follow-up [40] , though greater marijuana use was associated with unhealthy behaviors [22] . In our data, greater marijuana use is associated with greater physical activity, without adjustment for other characteristics. This is association is likely confounded by smoking status; we do not observe an association between physical activity and marijuana use for individuals who report never smoking cigarettes or who are current cigarette smokers and former cigarette smokers may have increased their level of physical activity in the time since quitting smoking cigarettes (e.g., medical recommendation, improved physical fitness, or ability to be physically active). The dearth of data on long-term marijuana use warrants more research on the prolonged health effects of marijuana use, particularly considering the uncertainty surrounding the prevalence of marijuana use before and after legalization of medicinal and recreational use in the US [2] [3] [4] . This study was in a large biracial cohort with standardized data collection and phenotyping at all 8 exams and high retention of the original cohort at year 25. CARDIA participants were asked about drug use at each examination with a self-administered questionnaire, potentially mitigating under-reporting due to social desirability concerns. While a majority of CARDIA participants reported ever using marijuana, the average cumulative lifetime quantity was low. This may prevent us from observing an association and also limits the interpretation of this association at heavier quantities of lifetime marijuana use. Our results may generalize to US populations of similar demographic and socioeconomic makeup. Some limitations of our study merit discussion. First, abdominal CT scans were performed at year 25, precluding investigation of change in abdominal adipose tissue. Second, we excluded individuals who were lost to follow-up and were missing covariate data at year 25. We employed statistical techniques to minimize the influence of cohort attrition on our estimates, observing minimal impact on our estimates. Third, mode of marijuana use and mixing with other substances (i.e. tobacco) was not assessed. Lastly, this is an observational study where assessment of marijuana use and other health behaviors occurred every 2-5 years and is subject to unmeasured confounding.
Our findings suggest marijuana use during young adulthood is not associated with abdominal adipose tissue accumulation in middle adulthood. In our study, neither self-reported cumulative use of marijuana nor current marijuana use were associated with volume of total abdominal adipose tissue, visceral adipose tissue, subcutaneous adipose tissue, intermuscular adipose tissue, or mean liver attenuation. We caution that additional data is needed to confirm these results and individuals who use marijuana should consider the severity of known acute and chronic health effects of marijuana use.
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Additional Supporting Information may be found online in the supporting information tab for this article. (2010) (2011) . Figure S1 Association between cumulative lifetime marijuana use and total abdominal adipose tissue. The restricted cubic spline of total abdominal adipose tissue (mL) corresponds to the left y-axis and the histogram plots the frequency of individuals corresponding to the right yaxis. Both y-axes are plotted according to marijuana-years on the x-axis. 
